论文信息 - Commercialization of a protein product from transgenic maize

Commercialization of a protein product from transgenic maize

The concept of plants as factories was launched approximately 5 years ago as a method for bio-manufacturing pharmaceuticals, vaccines and industrial enzymes. The advantages of the plant system include low-cost manufacturing with limited capital investment for growing the biomass, easy scale-up with planting of increased acreage and a system without the threat of animal pathogens whether viral, bacterial or prion.

Elizabeth E. Hood | Susan L. Woodard | E. Hood | S. Woodard

[1] S. Streatfield,et al. A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine , 2004, Vaccine.

[2] P. A. Sweeney. A Warehouse of Ideas; Developing and Using Intellectual Property , 2002 .

[3] John A. Howard,et al. Bioindustrial and Biopharmaceutical Products Produced in Plants , 2005 .

[4] J. Gasdaska,et al. Advantages of Therapeutic Protein Production in the Aquatic Plant Lemna , 2003 .

[5] M. B. Hein,et al. Production of secretory IgA antibodies in plants , 1996 .

[6] John A. Howard,et al. Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification , 1997, Molecular Breeding.

[7] J. Lindbo,et al. Viral Vector Expression of Foreign Proteins in Plants , 2002 .

[8] N. Huang. High-Level Protein Expression System Uses Self-Pollinating Crops As Hosts , 2004 .

[9] Jeffrey R. Lane,et al. Maize (Zea mays)‐derived bovine trypsin: characterization of the first large‐scale, commercial protein product from transgenic plants , 2003, Biotechnology and applied biochemistry.

[10] E. Hood,et al. Industrial Proteins Produced from Transgenic Plants , 2002 .

[11] K. Donnelly,et al. A Quantitative Safety Assessment Model For Transgenic Protein Products Produced In Agricultural Crops , 2004 .